Boston MedTech Advisors

Description

Boston MedTech CRO is a full-service provider, offering a suite of services, carefully customized to meet the unique requirements of the business or entity sponsoring the clinical study.

The first step towards a successful clinical trial outcome is an effective, comprehensive study design. Boston MedTech CRO develops clinical study plans and protocols in support of regulatory submissions, quality audits, marketing plans and reimbursement activities. From the first step of establishing the methodological approach through the formulation of study endpoints and patient selection, we provide the knowledge, support and practical experience required to best address the specific business goals of each company.

A privately held start-up was looking to qualify an innovative device-based treatment to reduce fatigue in HCV patients, to improve their quality of life. The device sought to improve fatigue through daily treatments, which would occur in the patient’s home. The company selected Boston MedTech Advisors to devise its regulatory strategy, and Boston MedTech CRO to provide full service support for a pivotal clinical trial to evaluate the safety and efficacy of this treatment.

Boston MedTech Advisors (BMTA) is the parent company of Boston MedTech CRO. BMTA assists its client companies and healthcare organizations develop strategies and plans supporting the introduction of new medical technologies and procedures, and to develop product adoption, and respectively, shareholder value.

Fact sheet

Companies nearby